Adaptación y validación de la Frontotemporal Dementia Rating Scale (FTD-FRS) al castellano

Turró‐Garriga, Oriol; Contreras, C. Hermoso; Cladera, J. Olives; Mioshi, Eneida; Valero, Carmelo Pelegrín; Pueyo, Javier Olivera; Garré-Olmo, Josep; Sánchez‐Valle, Raquel

doi:10.1016/j.nrl.2015.12.004

Cited by 5 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Portuguese and Spanish language adaptations of the Frontotemporal Dementia Rating Scale (FTD-FRS) 114 have been shown to have good utility for assessing and monitoring illness severity. 115,116 The Frontal Systems Behavior Scale (FrSBE), developed for measuring behavioral disturbances related to frontal lobe functions, with subscales for apathy, executive dysfunction, and disinhibition, 117 has been shown to be useful for discriminating AD from FTD. A translated version has been created and used in the linguistically diverse FTD patient population in India.…”

Section: Behavioral Rating Scalesmentioning

confidence: 99%

Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

Franzen

Nuytemans

Bourdage

et al. 2023

Alzheimer's & Dementia

View full text Add to dashboard Cite

Frontotemporal dementia (FTD) is one of the leading causes of dementia before age 65 and often manifests as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive aphasia). FTD's exact clinical presentation varies by culture, language, education, social norms, and other socioeconomic factors; current research and clinical practice, however, is mainly based on studies conducted in North America and Western Europe. Changes in diagnostic criteria and procedures as well as new or adapted cognitive tests are likely needed to take into consideration global diversity. This perspective paper by two professional interest areas of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment examines how increasing global diversity impacts the clinical presentation, screening, assessment, and diagnosis of FTD and its treatment and care. It subsequently provides recommendations to address immediate needs to advance global FTD research and clinical practice.

show abstract

Section: Behavioral Rating Scalesmentioning

confidence: 99%

Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

Franzen

Nuytemans

Bourdage

et al. 2023

Alzheimer's & Dementia

View full text Add to dashboard Cite

show abstract

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Alcolea

Clarimón

Carmona-Iragui

et al. 2019

A&D Transl Res & Clin Interv

101

View full text Add to dashboard Cite

Introduction The SPIN (Sant Pau Initiative on Neurodegeneration) cohort is a multimodal biomarker platform designed for neurodegenerative disease research following an integrative approach. Methods Participants of the SPIN cohort provide informed consent to donate blood and cerebrospinal fluid samples, receive detailed neurological and neuropsychological evaluations, and undergo a structural 3T brain MRI scan. A subset also undergoes other functional or imaging studies (video‐polysomnogram, 18F‐fluorodeoxyglucose PET, amyloid PET, Tau PET). Participants are followed annually for a minimum of 4 years, with repeated cerebrospinal fluid collection and imaging studies performed every other year, and brain donation is encouraged. Results The integration of clinical, neuropsychological, genetic, biochemical, imaging, and neuropathological information and the harmonization of protocols under the same umbrella allows the discovery and validation of key biomarkers across several neurodegenerative diseases. Discussion We describe our particular 10‐year experience and how different research projects were unified under an umbrella biomarker program, which might be of help to other research teams pursuing similar approaches.

show abstract

Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients

Lima-Silva

Bahia

Cecchini

et al. 2018

Alzheimer Disease &Amp; Associated Disorders

View full text Add to dashboard Cite

show abstract

Adaptación y validación de la Frontotemporal Dementia Rating Scale (FTD-FRS) al castellano

Abstract: This process of validating the Spanish translation of the FTD-FRS yielded satisfactory results for validity and unidimensionality (severity) in the assessment of patients with FTD.

Cited by 5 publications

References 29 publications

Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients

Contact Info

Product

Resources

About